IO Biotech, Inc. (IOBTQ) Cash from Operations (2020 - 2025)

IO Biotech (IOBTQ) has 6 years of Cash from Operations data on file, last reported at 18478000.0 in Q3 2025.

• Quarterly Cash from Operations rose 11.2% year-over-year to 18478000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 80996000.0 (up 5.29% YoY) and the FY2024 annual result came in at 82347000.0, down 14.79% from the prior year.
• Cash from Operations grew to 18478000.0 in Q3 2025, from 19822000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 3892000.0 in Q1 2021 to a low of 24932000.0 in Q1 2024.
• A 5-year average of 16622631.58 and a median of 18262000.0 in 2023 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2021 — Cash from Operations plunged 521.85% — and 2022, when it jumped 34.9%.
• Tracing IOBTQ's Cash from Operations over 5 years: stood at 19240000.0 in 2021, then jumped by 34.9% to 12526000.0 in 2022, then slumped by 81.98% to 22795000.0 in 2023, then advanced by 13.91% to 19625000.0 in 2024, then climbed by 5.84% to 18478000.0 in 2025.
• The last three Cash from Operations figures came in at 18478000.0 (Q3 2025), 19822000.0 (Q2 2025), and 23071000.0 (Q1 2025), per Business Quant data.